James G. Porterfield

1.3k total citations · 1 hit paper
22 papers, 923 citations indexed

About

James G. Porterfield is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Neurology. According to data from OpenAlex, James G. Porterfield has authored 22 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Neurology. Recurrent topics in James G. Porterfield's work include Cardiac Arrhythmias and Treatments (12 papers), Cardiac pacing and defibrillation studies (11 papers) and Cardiac electrophysiology and arrhythmias (11 papers). James G. Porterfield is often cited by papers focused on Cardiac Arrhythmias and Treatments (12 papers), Cardiac pacing and defibrillation studies (11 papers) and Cardiac electrophysiology and arrhythmias (11 papers). James G. Porterfield collaborates with scholars based in United States, Sweden and Canada. James G. Porterfield's co-authors include Rahul N. Doshi, Gery Tomassoni, Vivek Y. Reddy, Srinivas R. Dukkipati, Imran Niazi, N.A. Mark Estes, Daniel J. Cantillon, John Ip, Kenneth Plunkitt and Paul A. Friedman and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and The American Journal of Cardiology.

In The Last Decade

James G. Porterfield

22 papers receiving 884 citations

Hit Papers

Percutaneous Implantation... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James G. Porterfield United States 13 804 112 79 71 65 22 923
David T. Martin United States 17 870 1.1× 114 1.0× 28 0.4× 72 1.0× 46 0.7× 53 995
J.‐Y. Le Heuzey France 16 1.1k 1.3× 141 1.3× 150 1.9× 131 1.8× 74 1.1× 47 1.2k
Giosuè Mascioli Italy 15 932 1.2× 213 1.9× 213 2.7× 40 0.6× 46 0.7× 58 1.1k
Jürgen Tebbenjohanns Germany 19 1.4k 1.7× 168 1.5× 41 0.5× 56 0.8× 33 0.5× 66 1.5k
John J. Rozanski United States 15 811 1.0× 148 1.3× 86 1.1× 48 0.7× 46 0.7× 46 927
P Djiane France 14 747 0.9× 195 1.7× 65 0.8× 122 1.7× 11 0.2× 82 862
Lawrence D. German United States 21 2.0k 2.5× 264 2.4× 66 0.8× 37 0.5× 60 0.9× 54 2.1k
Ulrika Birgersdotter‐Green United States 20 1.6k 2.0× 198 1.8× 52 0.7× 62 0.9× 44 0.7× 117 1.7k
Sven Reek Germany 15 1.2k 1.5× 173 1.5× 23 0.3× 23 0.3× 49 0.8× 38 1.3k
Benoit Coutu Canada 14 1.2k 1.5× 179 1.6× 48 0.6× 76 1.1× 10 0.2× 36 1.3k

Countries citing papers authored by James G. Porterfield

Since Specialization
Citations

This map shows the geographic impact of James G. Porterfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James G. Porterfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James G. Porterfield more than expected).

Fields of papers citing papers by James G. Porterfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James G. Porterfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James G. Porterfield. The network helps show where James G. Porterfield may publish in the future.

Co-authorship network of co-authors of James G. Porterfield

This figure shows the co-authorship network connecting the top 25 collaborators of James G. Porterfield. A scholar is included among the top collaborators of James G. Porterfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James G. Porterfield. James G. Porterfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, Vivek Y., Derek V. Exner, Daniel J. Cantillon, et al.. (2015). Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. New England Journal of Medicine. 373(12). 1125–1135. 333 indexed citations breakdown →
2.
Heist, E. Kevin, John M. Herre, Philip F. Binkley, et al.. (2014). Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring Study). The American Journal of Cardiology. 114(8). 1249–1256. 41 indexed citations
3.
Binkley, Philip F., James G. Porterfield, Scott L. Beau, et al.. (2012). Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients. Journal of Interventional Cardiac Electrophysiology. 35(2). 197–206. 17 indexed citations
4.
Porterfield, James G., Karl Heinz Kuck, Raffaele Corbisiero, et al.. (2009). Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population. Journal of Cardiovascular Electrophysiology. 21(5). 551–556. 38 indexed citations
5.
Baker, James H., John P. McKenzie, Scott L. Beau, et al.. (2006). Acute Evaluation of Programmer‐Guided AV/PV and VV Delay Optimization Comparing an IEGM Method and Echocardiogram for Cardiac Resynchronization Therapy in Heart Failure Patients and Dual‐Chamber ICD Implants. Journal of Cardiovascular Electrophysiology. 18(2). 185–191. 70 indexed citations
6.
Higgins, Steven L., John M. Herre, Andrew E. Epstein, et al.. (2000). A C OMPARISON OF B IPHASIC AND M ONOPHASIC S HOCKS FOR E XTERNAL D EFIBRILLATION. Prehospital Emergency Care. 4(4). 305–313. 60 indexed citations
7.
Porterfield, James G., et al.. (1997). Daily Variations in the Occurrence of Symptomatic Supraventricular Tachycardia as Determined by Ambulatory Event Monitoring. The American Journal of Cardiology. 80(7). 889–891. 5 indexed citations
8.
Porterfield, James G., et al.. (1996). Compatibility of a nonthoracotomy lead system with a biphasic implantable cardioverter-defibrillator. The American Journal of Cardiology. 77(8). 586–590. 6 indexed citations
9.
Porterfield, James G., et al.. (1996). The Shocking Lung Mass: A Case Report. Pacing and Clinical Electrophysiology. 19(9). 1398–1399. 1 indexed citations
10.
Porterfield, James G., et al.. (1993). Conversion Rates of Induced Versus Spontaneous Ventricular Tachycardia by a Third Generation Cardioverter Defibrillator. Pacing and Clinical Electrophysiology. 16(1). 170–173. 23 indexed citations
11.
Porterfield, James G., et al.. (1993). Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy. The American Journal of Cardiology. 72(3). 301–304. 12 indexed citations
12.
Porterfield, James G., et al.. (1991). A Prospective Study Utilizing a Transtelephonic Electrocardiographic Transmission Program to Manage Patients in the First Several Months Post‐ICD Implant. Pacing and Clinical Electrophysiology. 14(2). 308–311. 12 indexed citations
13.
Porterfield, James G., et al.. (1991). Long‐Term Community Hospital Experience with the Internal Defibrillator. Pacing and Clinical Electrophysiology. 14(2). 263–265. 7 indexed citations
14.
Porterfield, James G., et al.. (1991). Ninety‐Six Episodes of Spontaneous Ventricular Tachycardia in 1 Week: Success of Ramp Pacing by a Pacer‐Cardioverter‐Defibrillator. Pacing and Clinical Electrophysiology. 14(10). 1440–1443. 5 indexed citations
15.
Porterfield, James G., et al.. (1990). HOW DIGOXIN INTERACTS WITH OTHER DRUGS. Nursing. 20(1). 50–51. 3 indexed citations
16.
Porterfield, James G., et al.. (1989). Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. The American Journal of Cardiology. 63(1). 114–116. 50 indexed citations
17.
Wagner, John A., Frederic L. Sax, Harlan F. Weisman, et al.. (1989). Calcium-Antagonist Receptors in the Atrial Tissue of Patients with Hypertrophic Cardiomyopathy. New England Journal of Medicine. 320(12). 755–761. 75 indexed citations
18.
Dean, Patrick J., et al.. (1987). Amiodarone-Associated Pulmonary Toxicity: A Clinical and Pathologic Study of Eleven Cases. American Journal of Clinical Pathology. 87(1). 7–13. 80 indexed citations
19.
Podrid, Philip J., Bernard Lown, Steven Lampert, et al.. (1983). Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia. American Heart Journal. 105(2). 181–188. 51 indexed citations
20.
Podrid, Philip J., et al.. (1981). Programmed premature stimulation as a guide to antiarrhythmic therapy for malignant ventricular arrhythmia in the absence of ambient ectopy. The American Journal of Cardiology. 47. 497–497. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026